These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 13690428)

  • 1. [Resistance of the Koch bacillus in tuberculous lesions].
    CANETTI G
    Pathol Biol; 1960 Sep; 8():1643-9. PubMed ID: 13690428
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the drug resistance of tubercle bacilli before and after chemotherapy of pulmonary tuberculosis].
    OKUBO H
    Kekkaku; 1961 Nov; 36():712-9. PubMed ID: 14481598
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study on drug resistance of the tubercle bacilli in the wall of cavity of the resected tuberculous lungs].
    UEDA T
    Osaka City Med J; 1961 Jan; 10():139-54. PubMed ID: 13923491
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug-resistance of tubercle bacilli in patients with pulmonary tuberculosis at the time of entering hospital].
    NISHIZAWA N; KONISHIKE J; MOROKI N; OKADA J; TAKAYAMA Y; WATANABE M; ODA K
    Iryo; 1961 Mar; 15():212-6. PubMed ID: 14480001
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical studies on the alpha-ethyl-thioisonicotinamide (1314Th) resistance of tubercle bacilli, with special regard to the resistance test by direct method and the mode of development of resistance].
    TSUKAMURA M; ABO T
    Kekkaku; 1961 Jun; 336():361-5. PubMed ID: 13778438
    [No Abstract]   [Full Text] [Related]  

  • 6. [Resistance of the Koch bacillus in tuberculous children].
    Ibáñez S; Herrera L; Contreras R
    Rev Chil Pediatr; 1966 Jan; 37(1):35-40. PubMed ID: 4958122
    [No Abstract]   [Full Text] [Related]  

  • 7. [Individual differences in the pattern of resistance development of tubercle bacilli to streptomycin, PAS and isoniazid in tuberculous patients].
    TSUKAMURA M
    Kekkaku; 1960 Oct; 35():704-8. PubMed ID: 13778449
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aspects of chemoresistance of Koch bacillus in the period 1971-1980 in the Constanţa tuberculosis outpatient clinic].
    Toldişan V; Didilescu C; Filip G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(1):53-7. PubMed ID: 6312536
    [No Abstract]   [Full Text] [Related]  

  • 9. THE INCIDENCE OF VIABLE TUBERCLE BACILLI IN TUBERCULOUS LESIONS FOLLOWING CHEMOTHERAPY: COMPARISON OF TWO CULTURE TECHNIQUES.
    KAZLOWSKI JP; RALEIGH JW; STEENKEN W
    Tubercle; 1964 Jun; 45():101-5. PubMed ID: 14161907
    [No Abstract]   [Full Text] [Related]  

  • 10. Difficulties in the diagnosis and treatment of drug-resistant tuberculosis and tuberculous empyema.
    Glisson J; Mehta JB
    J Tenn Med Assoc; 1992 Sep; 85(9):419-22. PubMed ID: 1405623
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of pulmonary tuberculosis with cyanacetic acid hydrazide and study of the resistance of Koch's bacillus to the principle antituberculosis drugs].
    TZELEPIDES P; KARADEMOS N; TZOUNRANES A; KOUPHONIKOLAS N; GOUNARES G
    Hell Iatr; 1961 Feb; 30():129-50. PubMed ID: 13778907
    [No Abstract]   [Full Text] [Related]  

  • 12. [OUR EXPERIENCE WITH THE TREATMENT OF KOCH'S BACILLUS POSITIVE CHRONIC INFECTION BEFORE THE APPEARANCE OF INDIRECT RESISTANCE].
    PANIC R
    Tuberkuloza; 1964; 16():442-6. PubMed ID: 14306428
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative bacillary response to treatment in Mycobacterium tuberculosis infected and M. africanum infected adults with pulmonary tuberculosis.
    Joloba ML; Johnson JL; Namale A; Morrissey A; Assegghai AE; Rüsch-Gerdes S; Mugerwa RD; Ellner JJ; Eisenach KD
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):579-82. PubMed ID: 11409588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of secondary chemoresistance of Koch bacillus at the present time].
    Jemna I; Lego I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(4):243-4. PubMed ID: 6278569
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study on the current incidence of bovine tuberculosis bacillus (Mycobacterium bovis) and on resistance to antitubercular antibiotics in human pulmonary tuberculosis].
    Viallier MJ
    J Med Lyon; 1968 Dec; 49(154):1857-86. PubMed ID: 4975074
    [No Abstract]   [Full Text] [Related]  

  • 16. Sterilization of tuberculous lesions in man.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1969 Oct; 16(1):37-48. PubMed ID: 4987560
    [No Abstract]   [Full Text] [Related]  

  • 17. [L forms of Mycobacterium tuberculosis and their clinico-epidemiological significance].
    Anastasatu C; Moldovan O
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(3):203-13. PubMed ID: 3001898
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of determination of drug resistance in Mycobacterium tuberculosis for successful treatment of pulmonary tuberculosis].
    Novozhilova IA
    Probl Tuberk Bolezn Legk; 2004; (4):29-31. PubMed ID: 15171041
    [No Abstract]   [Full Text] [Related]  

  • 19. An in vitro antituberculosis drug sensitivity of isolates of Mycobacterium tuberculosis from human cases of pulmonary tuberculosis.
    Shah VM; Jhala CI
    J Indian Med Assoc; 1976 Aug; 67(3):57-9. PubMed ID: 828192
    [No Abstract]   [Full Text] [Related]  

  • 20. [Secondary drug resistance of Mycobacterium tuberculosis in chronic destructive forms of pulmonary tuberculosis].
    Poliakova AN; Ianovskaia OM; Samuliak ID; Vasilik GV; Matviĭchuk VM
    Vrach Delo; 1977 Jan; (1):97-9. PubMed ID: 402746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.